This study looked for biomarkers in the DNA of people with dyskenetic and ataxic CP with a goal to help in CP diagnosis. A previous study by the group found a DNA biomarker in people with spastic CP. This is important because early diagnosis of CP remains difficult; earlier diagnosis allows earlier interventions. Additionally, an understanding of the differing DNA markers for CP can indicate the best treatment plans for the patient, saving critical time for interventions.
- Early diagnosis of CP can decrease the severity of the disorder.
- Current diagnosis timelines range from 6 months old to several years old.
- Some data suggest that individuals with CP have an altered DNA methylation pattern – markers on an individual’s genetic material.
- These altered DNA patterns could be detected in newborns.
- Do all individuals with CP have an altered DNA methylation pattern?
- Can that altered DNA methylation pattern be used as a predictor of CP in infants?
Dr. Robert Akins PhD, Dr. Erin Crowgey PhD, Karyn Robinson MS, Stephanie Yeager MS